NEDD9 and acute myeloid leukemia: To explore the prognostic value of NEDD9 expression in AML, Kaplan‐Meier analysis was performed and revealed that AML patients with NEDD9 overexpression presented significantly shorter OS and LFS time than those without NEDD9 overexpression (Figure 3).